29 Oct
2020

Multi-billion dollar Bayer deal shows growing attraction of gene and cell therapy assets

The $4 billion AskBio buyout highlights new transaction patterns around cutting-edge biotech innovations and suggests industry M&A is continuing to recover.

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth